Adamis Pharmaceuticals Corp (ADMP)

[staxco]

Not only does the NIH find Tempol to be a promising oral antiviral treatment for Covid-19, but they say it's urgently needed. I have to believe an announcement of Tempol trials/studies with gov't funding will happen soon.

“We urgently need additional effective, accessible treatments for COVID-19,” said Diana W. Bianchi, M.D., NICHD Director. “An oral drug that prevents SARS-CoV-2 from replicating would be an important tool for reducing the severity of the disease.”